Late Breaking Clinical Research

SEPTEMBER 27, 2024 - SEPTEMBER 30, 2024 | GEORGIA WORLD CONGRESS CENTER, SIGNIA BY HILTON ATLANTA | ATLANTA, GA

Late Breaking Clinical Research submissions are now closed.

What is Late Breaking Clinical Research?

Late Breaking Clinical Research are always-popular sessions where speakers present the results of new or breaking research in heart failure. Featured on a plenary session stage, the Spotlight on Late Breaking Clinical Research sessions provide exposure and recognition for major randomized trials and registries that will likely have a significant impact on clinical practice or result in significant advances in the field. Additional rapid fire sessions will spotlight other clinical research in shorter oral presentations.



Submission Portal Opens: May 22, 2024
Submission Deadline: June 17, 2024

Research accepted for presentation will be: 

  • Select clinical trials presented during the Late Breaking Clinical Research plenary session
  • Timely clinical research will be spotlighted for short oral presentations during HFSA Spotlight/ Rapid Fire Abstracts session
  • Accepted Late Breaking Clinical Research abstracts from the plenary session will be published in an issue of the Journal of Cardiac Failure after the Annual Scientific Meeting. Authors will have the ability to update the submitted abstract prior to publication. JCF encourages all accepted Late Breaking Clinical Research submitters to submit full papers for further consideration
  • All late breaking data is embargoed until the day of the abstract presentation session

If an accepted late breaking clinical research abstract was submitted and accepted for abstract/poster presentation at the HFSA Annual Scientific Meeting, it needs to be withdrawn by August 2. Please notify Anna Leong at aleong@hfsa.org to ensure its status.

If you have any difficulty logging in, please contact hfsa@support.ctimeetingtech.com. The support team can assist with login issues and can upload materials on the submitter’s behalf.

Embargo Policy

Abstracts accepted are embargoed for release until the time of presentation at the Heart Failure Society of America's Annual Scientific Meeting.

The standard is that any company can announce at any time the following:

  1. Announcement that trial/research is completed
  2. That results will be presented at so and so date in such and such a meeting
  3. What did the trial/research assess - basic design, questions, study population, interventions, etc.
Submissions

Clinical research abstracts accepted for presentation will be: 

  • Either presented during the Late Breaking Clinical Research session
  • Or presented during a Rapid Fire Spotlight Oral session
  • Accepted Late Breaking Clinical Research abstracts from the plenary session will be published in an issue of the Journal of Cardiac Failure after the Annual Scientific Meeting. Authors will have the ability to update the submitted abstract prior to publication. JCF encourages all accepted Late Breaking Clinical Research to submit full papers for further consideration

All late breaking data is embargoed until the day of Late Breaking Clinical Research session.

If an accepted late breaking clinical research abstract was submitted and accepted for general abstract/poster presentation at the HFSA Annual Scientific Meeting, it needs to be withdrawn by August 2, 2024.

Sign Up for ASM News

Get your name added to our mailing list to ensure that you receive the latest news about submitting your science, registering, and more!